To add more protein to your life, you can consider adding animal proteins like eggs, cottage cheese, Greek yogurt, and ...

An analysis of over 400,000 patients with T1D revealed a rise in prescribing for glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors over the past decade.

The GLP-1 RA semaglutide was associated with a 40%-70% reduced risk for first-time diagnosis of AD in patients with type 2 diabetes, real-world data show.

Type 2 diabetics taking the drug had a lower risk of Alzheimer’s compared to patients on other diabetes drugs Semaglutide is ...

The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may ...

THURSDAY, Oct. 24, 2024 (HealthDay News) -- Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and ...

Less than a week after the U.S. Food & Drug Administration (FDA) determined that the shortage of the tirzepatide injection, a glucagon-like peptide ...

The UK medicines regulator has asked doctors to look out for “signs of misuse” of weight loss drugs among their patients. It ...

The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...

The Medicaid rate hike will mitigate headwinds in that line of Molina Healthcare's business, which has seen higher costs ...